• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes

byAstrid BradshawandAlisha Yi
July 7, 2025
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click here to read this study in NEJM.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes

Metformin remains a leading candidate for pharmacologic longevity intervention

GLP-1 receptor agonists move from weight loss into the longevity conversation

Tags: cagrilintidediabetesdiabetes mellitussemaglutidetype 2 diabetesType 2 Diabetes Mellitus
Previous Post

2 Minute Medicine Rewind July 7, 2025

Next Post

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

RelatedReports

Food environment associated with gestational diabetes
Chronic Disease

Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes

May 25, 2026
Metformin treats Fragile X syndrome symptoms in mice [PreClinical]
Chronic Disease

Metformin remains a leading candidate for pharmacologic longevity intervention

May 19, 2026
Weight loss surgery may reduce risk of developing type 2 diabetes
Chronic Disease

GLP-1 receptor agonists move from weight loss into the longevity conversation

May 18, 2026
Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

April 3, 2026
Next Post
Lessons from real-world implementation of lung cancer screening

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

Primary thromboembolism prophylaxis may be effective in advanced cancer

AAV gene therapy shows durable benefit in hemophilia B

Baby-led weaning not linked to increased choking

Abridge drafts pediatric notes so physicians stay with the kids, not the keyboard

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality
  • A novel therapy targeting γ-aminobutyric acid is safe and may be effective in major depressive disorder
  • Intra-arterial alteplase after thrombectomy improves three-month functional recovery in large vessel stroke
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.